期刊文献+

儿童心脏标志物检测的临床意义 被引量:1

Role of cardiac markers in children
下载PDF
导出
摘要 近年来,越来越多的研究证实了心脏标志物在不同疾病儿童患者中的诊断价值和临床应用前景,在心肌炎、心肌病、先天性心脏病(CHD)和心力衰竭等儿童心源性疾病的诊断和预后评估中有重要的临床意义,在判断儿童免疫相关和其他全身性疾病导致的心脏功能、心肌损伤程度,预测并发症和诊疗效果方面的研究也有新进展。由于儿童各组织、器官尚处于生长发育阶段,不同年龄段儿童,尤其是新生儿,心脏标志物检测结果存在明显差异,使检测报告的解释更具挑战性。心脏标志物在儿童患者疾病诊疗中的应用需侧重于新的分析方法、不同年龄患儿检测指标参考区间的建立和更多的循证研究,发布基于循证数据的相关指南或专家共识,推动临床规范应用儿童患者心脏标志物检测结果。 In the recent years,an increasing number of studies have confirmed the diagnostic value and clinical application prospects of cardiac markers in different diseases,such as myocarditis,cardiomyopathy,congenital heart disease(CHD)and heart failure among children.In addition,it has made new progress in judging cardiac function,the degree of myocardial injury,the occurrence of complications and the effect of diagnosis and treatment of immune-related and other systemic diseases.Children's tissues and organs are still in growth and development stage,there are differences in the determination results of cardiac markers in children with different ages,especially in newborns,which makes the interpretation of determination reports more challenging.Therefore,future researches should focus on new analytical methods,the establishment of biological reference intervals for different ages and more evidence-based research in the diagnosis and treatment of children.Related guidelines or expert consensus should be issued to promote the clinical standard application of cardiac marker determination results in children.
作者 张欣 马丽娟 ZHANG Xin;MA Lijuan(Department of Clinical Laboratory,the Children's Hospital Affiliated to Capital Institute of Pediatrics,Beijing 100020,China)
出处 《检验医学》 CAS 2023年第6期505-509,M0004,共6页 Laboratory Medicine
基金 国家重点研发计划重点专项子课题(2019YFF0216502)。
关键词 儿童 心脏标志物 心肌肌钙蛋白 B型钠尿肽 Children Cardiac marker Cardiac troponin B-type natriuretic peptide
  • 相关文献

参考文献8

二级参考文献60

  • 1龙云霞,李香.青岛市表面健康人群N-端B型钠尿肽参考范围调查研究[J].医学检验与临床,2008,20(4):61-62. 被引量:6
  • 2张向阳,朱继红.脑钠肽前体N-末端肽的临床意义[J].北京大学学报(医学版),2004,36(5):547-549. 被引量:5
  • 3潘柏申,蔡乃绳,李清,范维琥,李勇,郭玮,周琰,陶青.表面健康人群氨基末端B型利钠肽参考范围调查[J].中华检验医学杂志,2006,29(1):23-26. 被引量:66
  • 4柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2157
  • 5Farah CS, Reinach FC. The troponin complex and regulation of muscle contraction. FASEB J, 1995,9:755-767.
  • 6Katus HA, Remppis A, Scheffold T, et al. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol, 1991,67 : 1360-1367.
  • 7Morrow DA, Cannon CP, Jesse RL, et al. National academy of clinical biochemistry laboratory medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clinical Chemistry, 2007,53 : 552- 574.
  • 8Vasile VC, Saenger AK, Kroning JM, et al. Biological and analytical variability of a novel high-sensitivitycardiac troponin T assay. Clin Chem, 2010,56 : 1086-1090.
  • 9Apple FS, Collinson PO, IFCC task force on clinical applications of cardiac biomarkers. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem, 2012,58:54-61.
  • 10Weber M, Bazzino O, Navarro Estrada JL, et al. Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome. Am Heart J, 2011,162:81-88.

共引文献5305

同被引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部